Posted on August 20, 2009 by Nancy Houser

This last June,  Germany’s infectious disease federal agency stated that signs of an upcoming mutation of the H1N1 virus (swine flu) may possibly be occurring, warning that it could be spreading  in a much more aggressive form. Also, serious concern over the developing swine flu in Australia and South America is causing experts such as Joerg Hacker of the Robert Koch Institute for infectious diseases to state:

“It’s possible the virus has mutated. In autumn the mutated form could spread to the northern hemisphere and back to Germany,” Hacker told a news conference in Berlin.

SWINE FLU STATISTICS

As of yesterday, Germany has 12,500  confirmed swine flu cases with 300-500 daily infections being reported (WHO map). With 50 million doses of the swine flu vaccine coming by the end of September, it would cost the country 600 million euros ($852 million) and one billion euros.

*

*

On a global basis the H1N1 count is:

• Africa – confirmed cases 1,469; deaths 3
• the Americas – confirmed cases 105,882; deaths 1,579
• Eastern Mediterranean – confirmed cases 2,532; deaths 8
• Europe – confirmed cases 32,00; deaths 53
• South East Asia – confirmed cases 13,172; deaths 106
• Western Pacific – confirmed cases 27,111; deaths 50
• TOTAL CONFIRMED CASES 182,166; DEATHS 1,799

Considered Germany’s biggest mass vaccination in postwar history (dw-world.de) the vaccines are still undergoing clinical testing.  The amount that will be coming into Germany is only enough to immunize about 1/3 of their population against the H1N1 virus. The first people to be vaccinated are those with chronic illnesses or immune disorders, pregnant women, healthcare workers, and emergency services personal. It is stated that those with private or public health insurance will be able to get the H1N1 vaccine free of cost (???) with each German state carrying out their own immunization details. Everyone else will have to pay or not be able to get one.

The World Health Organization is advising all global governments to prepare for a very long-term battle against the swine flu pandemic, with it perhaps mixing with the H5N1 (bird flu) virus for a more deadly form of the disease, according to WHO Director-General Dr. Margaret Chan.

TESTING OF SWINE FLU VACCINE SOON TO START ON CHILDREN IN U.S.

The United States swine flu vaccine market is being supplied by AstraZeneca’s MedImmune unit, CSL, GlaxoSmithKline Plc, Novartis AG and Sanofi. The company which is supplying the vaccine for two of the children’s swine flu vaccine trials, according to the National Institute of Allergy and Infectious Disease, is Sanofi-Aventis’ for ages 6 months to 17 years.

By mid-October, a mass vaccination will be begun in the United States with 5 million doses, as compared to Germany’s 50  million doses of the vaccine.The vaccine companies will be making and testing their vaccines the same time as the United States officials will begin the mass vaccination.

Related posts:

• Swine Flu Vaccine Reported More Deadly Than The Swine Flu Itself
• Swine Flu Now Transfers to Birds
• Extraordinary Meeting of Swine Flu Experts Held in Geneva
• Iowa cat diagnosed positive for H1N1 Swine Flu
• Charges Against WHO and UN for Using Swine Flu Vaccine for Bioterrorism and Mass Murder Attempts